Indegene Ltd. IPO

Indegene is a digital-first life sciences commercialization partner. They focus on biopharma, biotech, and medical device companies, helping them develop, launch, and grow their products throughout the lifecycle. With over 20 years of experience, they combine deep industry knowledge with digital solutions. Their services span marketing, medical affairs, clinical research, and regulatory submissions. Notably, they partner with the top 20 global biopharmaceutical companies.

RHP
View
DRHP
View
Open Date

2024-05-06

Close Date

2024-05-08

Indegene Ltd. IPO Details

Check out the issue details for Indegene Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 452

Price Band

₹ 430 - 452

Issue Size

1841.76 Cr.

Issue Type

Book Built

Open

2024-05-06

Close

2024-05-08

Listingprice

₹ 655

ListingGain

44.91%

Listing Date

2024-05-13

CMP

₹ 599.25

Current Return

32.58%

Indegene Ltd. News

Indegene informs about analyst meet22 May, 12:06PM Indegene partners with Indian Institute of Cerebral Palsy19 May, 12:20PM Indegene informs about press release19 May, 11:45AM Indegene partners with Indian School of Public Policy7 May, 11:07AM Indegene - Quaterly Results28 Apr, 7:48PM Indegene - Quaterly Results28 Apr, 7:48PM Indegene informs about updates24 Apr, 5:23PM Indegene launches new center in London 20 Mar, 9:27AM Indegene recognized among Financial Times High-Growth Companies in Asia-Pacific 202518 Mar, 4:43PM Indegene informs about notice of postal ballot17 Mar, 4:55PM Indegene informs about press release10 Mar, 11:39AM Indegene launches Cortex 24 Feb, 1:00PM Indegene informs about board meeting proceedings24 Feb, 12:23PM Indegene informs about press release24 Feb, 11:48AM Indegene informs about investor meet 20 Feb, 5:12PM Indegene informs about board meeting 18 Feb, 5:30PM Indegene launches new entity in Spain6 Feb, 2:42PM Indegene - Quaterly Results30 Jan, 5:37PM Indegene - Quaterly Results30 Jan, 5:37PM Indegene - Quaterly Results30 Jan, 5:37PM

Company Financials

You can get the following financial statements of Indegene Ltd. as of now.

Company Name

Indegene Ltd.

Exchange

NSE: INDGN BSE: 544172

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Indegene Limited IPO is as:

  • The issue size of the IPO is 1841.76 Cr.
  • The price band for Indegene Limited IPO is Rs 430 to Rs 452.
  • The employees of the company will get a discount of Rs 30. 
  • The shares of Indegene Limited IPO will list on 13th May 2024.
  • The latest tentative GMP of Indegene Limited IPO is Rs 260.
  • The shares of Indegene Limited IPO is subscribed 70.30 Times as of 8th May 2024.

 

Indegene Limited IPO Valuation

The approx valuation of Indegene Limited IPO based on its price band and DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 452
Existing Shares (Qty) 22.24 Cr
Fresh Issue 760 Cr
Market Cap 10,812.48 Cr
EPS (FY23) Rs 12.03
PE Ratio 37.57x

 

Indegene Limited IPO Issue Size

Indegene Limited IPO issue size is 1841.76 Cr. 

Issue Amount
Fresh Issue 760 Cr
Offer For Sale 1081.76 Cr

 

Indegene Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 33 shares and a maximum of 13 lots of 429 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 33 14,916
 Maximum 13 429 1,93,908

 

Indegene Limited IPO share offer

The shares of Indegene Limited IPO is subscribed 70.30 Times as of 8th May 2024. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 192.72 Times
Non-Institutional Minimum 15% 55.91 Times
Retail Individual Minimum 35% 7.86 Times
Employee 2,96,209 Shares 6.62 Times
Total   70.30 Times

Find below the dates for Indegene Limited IPO:

Schedule Date
Basis of Allotment 9 May 2024
Refunds 10 May 2024
Credit to Demat Account 10 May 2024
IPO Listing Date 13 May 2024

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 511 836.7 1005.7 1045.6 1093.6
Total Expenditure 361 668 828.1 877.6 913.1
Operating Profit 150 168.7 177.6 168 180.5
Other Income 24.5 27.8 37.1 50.3 90.4
Interest 3.5 3 6.4 6.6 6.2
Depreciation 17.6 23.6 31.7 31.1 26.2
Exceptional Items 3 0 0 0 0
Profit Before Tax 156.4 169.9 176.6 180.6 238.5
Provision for Tax 26.9 37.2 46.4 42.7 57.2
Net Profit 132.4 132.7 130.2 137.9 181.3
Adjusted EPS (Rs.) 0.69 0.53 0.59 0.62 0.76

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.3 0.4 44.3 44.4 47.9
Total Reserves 253.6 649.6 751 909.4 1840.3
Borrowings 0 0 0 0 0
Other N/C liabilities 7.1 48.8 59.4 53.2 50.4
Current liabilities 93.3 140.7 169.4 198.1 189.5
Total Liabilities 354.3 839.5 1024.1 1205.1 2128.1
Assets
Net Block 40.6 72 78.3 56.1 52.8
Capital WIP 0 0 0 0 3.6
Intangible WIP 0 0 0 0 0
Investments 83.4 83.4 231.5 385.4 471.3
Loans & Advances 12.3 149.5 11.1 12.5 382
Other N/C Assets 0.1 0.1 0.3 0.1 0.4
Current Assets 217.9 534.5 702.9 751 1218
Total Assets 354.3 839.5 1024.1 1205.1 2128.1
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Other Income 23.1 13.7 22.4 22.3 35.2
Profit Before Tax 60.4 45.1 61 66.1 66.4
Tax 11.5 12.5 16.2 16.2 12.2
Profit After Tax 48.9 32.6 44.8 49.9 54.2
Adjusted EPS (Rs) 2.2 1.36 1.87 2.09 2.26

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 159.9 169.9 176.6 180.6 238.5
Adjustment 11.3 15.5 32.8 2.5 -40.3
Changes in Assets & Liabilities -92.3 -111.3 -85.7 42.4 1.4
Tax Paid -25.6 -35.9 -41.8 -49.3 -70.6
Operating Cash Flow 53.3 38.2 81.9 176.2 129
Investing Cash Flow -34.1 -266.9 -51 -189 -824.3
Financing Cash Flow -37.1 244.9 -16.9 -15.8 717.3
Net Cash Flow -17.9 16.2 14 -28.6 22
X